This inventor holds 2 USPTO granted patents. Top assignees: Ortho-Mcneil Pharmaceutical Corp., Ortho-Muniel Pharmaceutical, Inc.. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2005
Title: Kristin M Averill: Innovator in Pharmaceutical Chemistry
Introduction
Kristin M Averill is a notable inventor based in High Bridge, NJ (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative work on arylindenopyridines. With a total of 2 patents, her inventions focus on therapeutic and prophylactic methods that address various medical disorders.
Latest Patents
Averill's latest patents include groundbreaking inventions related to arylindenopyridines. One of her patents provides novel arylindenopyridines of a specific formula, along with pharmaceutical compositions that are useful for treating disorders by reducing PDE activity in appropriate cells. Additionally, another patent offers therapeutic and prophylactic methods utilizing these pharmaceutical compositions, specifically targeting disorders that can be ameliorated by antagonizing Adenosine A2a receptors or reducing PDE activity.
Career Highlights
Throughout her career, Kristin M Averill has worked with prominent companies in the pharmaceutical industry, including Ortho-Muniel Pharmaceutical, Inc. and Ortho-McNeil Pharmaceutical Corporation. Her experience in these organizations has contributed to her expertise and success as an inventor.
Collaborations
Averill has collaborated with esteemed colleagues such as Geoffrey R Heintzelman and John H Dodd. These partnerships have likely enriched her research and development efforts in the pharmaceutical field.
Conclusion
Kristin M Averill stands out as an influential inventor in pharmaceutical chemistry, with her innovative patents paving the way for advancements in therapeutic methods. Her contributions continue to impact the medical community positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile